Editorial: Mass spectrometry-based proteogenomics - advances in mutant proteomics and clinical oncology.
作者信息
Végvári Akos, Nishimura Toshihide
机构信息
Department of Medical Biochemistry and Biophysics, Karolinska Institutet (KI), Stockholm, Sweden.
Department Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
出版信息
Front Oncol. 2024 Mar 21;14:1383838. doi: 10.3389/fonc.2024.1383838. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Mass spectrometry-based proteogenomics - advances in mutant proteomics and clinical oncology.社论：基于质谱的蛋白质基因组学——突变蛋白质组学与临床肿瘤学的进展
Front Oncol. 2024 Mar 21;14:1383838. doi: 10.3389/fonc.2024.1383838. eCollection 2024.
2
Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.基于质谱的临床蛋白质组学在癌症诊断和治疗中的应用。
Cancer Sci. 2023 May;114(5):1783-1791. doi: 10.1111/cas.15731. Epub 2023 Feb 1.
3
Proteogenomics for understanding oncology: recent advances and future prospects.用于肿瘤学研究的蛋白质基因组学：最新进展与未来展望
Expert Rev Proteomics. 2016;13(3):297-308. doi: 10.1586/14789450.2016.1136217. Epub 2016 Jan 25.
4
Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.蛋白质基因组学：从下一代测序（NGS）和基于质谱的蛋白质组学到精准医学。
Clin Chim Acta. 2019 Nov;498:38-46. doi: 10.1016/j.cca.2019.08.010. Epub 2019 Aug 14.
5
Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.基于质谱的蛋白质基因组学：精准医学的新治疗机会。
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:455-479. doi: 10.1146/annurev-pharmtox-022723-113921. Epub 2023 Sep 22.
6
Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.基于定量质谱的蛋白质基因组学在转移性前列腺癌细胞中的比较蛋白质组学分析和突变蛋白鉴定。
Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):273-286. doi: 10.21873/cgp.20132.
7
Clinical implications of recent advances in proteogenomics.蛋白质基因组学最新进展的临床意义
Expert Rev Proteomics. 2016;13(2):185-99. doi: 10.1586/14789450.2016.1132169. Epub 2016 Jan 13.
8
[Precision oncology from a proteogenomics perspective].[从蛋白质基因组学角度看精准肿瘤学]
Sheng Wu Gong Cheng Xue Bao. 2022 Oct 25;38(10):3616-3627. doi: 10.13345/j.cjb.220528.
9
Mutant Proteogenomics.突变蛋白质基因组学
Adv Exp Med Biol. 2016;926:77-91. doi: 10.1007/978-3-319-42316-6_6.
10
Cancer proteogenomics: current impact and future prospects.癌症蛋白质基因组学：当前影响与未来展望。
Nat Rev Cancer. 2022 May;22(5):298-313. doi: 10.1038/s41568-022-00446-5. Epub 2022 Mar 2.
本文引用的文献
1
Mutant Proteomics of Lung Adenocarcinomas Harboring Different Mutations.携带不同突变的肺腺癌的突变蛋白质组学
Front Oncol. 2020 Aug 25;10:1494. doi: 10.3389/fonc.2020.01494. eCollection 2020.
2
DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput.DIA-NN：神经网络和干扰校正可实现高通量下的深度蛋白质组覆盖。
Nat Methods. 2020 Jan;17(1):41-44. doi: 10.1038/s41592-019-0638-x. Epub 2019 Nov 25.
3
Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring.通过多重反应监测鉴定临床样本中前列腺特异性抗原的新型蛋白水解产物 (SNP-L132I)。
Mol Cell Proteomics. 2013 Oct;12(10):2761-73. doi: 10.1074/mcp.M113.028365. Epub 2013 Jul 10.
4
Allelic variation in human gene expression.人类基因表达中的等位基因变异。
Science. 2002 Aug 16;297(5584):1143. doi: 10.1126/science.1072545.
Zotero 插件